IARC Monographs Volume 111: evaluation of of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes
An International Agency for Research on Cancer (IARC) Working Group of international experts reviewed the available published scientific evidence and evaluated the carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes, including single-walled and multi-walled types. These assessments will be published as Volume 111 of the IARC Monographs.
A summary of the evaluations has now been published in The Lancet Oncology. Read article
A new genomic study of renal cell carcinomas (RCCs) uncovers novel pathways and genes affected by recurrent mutations, as well as a peculiar mutational profile in Romanian cases, suggesting that the processes underlying clear cell ccRCC tumorigenesis may vary in different populations.
Variation in genomic landscape of clear cell renal cell carcinoma across Europe
G. Scelo, Y. Riazalhosseini, et al.
Nature Communications, published Oct. 29, 2014.
DOI: 10.1038/ncomms6135 Read article
A new article reviews the sources and methods used in compiling the national cancer incidence and mortality estimates in GLOBOCAN 2012, and briefly describes the key results by cancer site and in 20 large areas of the world.
J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray (2014).
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer doi:10.1002/ijc.29210 PMID:25220842 Published online 9 October 2014 Read article
Planning and Developing Population-Based Cancer Registration in Low- and Middle-Income Settings
Authors: F. Bray, A. Znaor, P. Cueva, A. Korir, R. Swaminathan, A. Ullrich, S.A. Wang, and D.M. Parkin
This guidance document provides an overview of the key concepts in cancer registration, covering the steps involved in planning a registry, the sources of information a registry will need to access, methods for ensuring data quality, and how registry results should be reported. It will be of value to those who are seeking to establish a registry or are in the early stages of developing a registry. It covers the major components that need to be thought about when setting up a registry and ensuring that it provides the necessary information for its main stakeholders -especially those involved in cancer control planning. Download now
MORTALITY AND PREVALENCE
WORLDWIDE IN 2012